At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- White blood cell and blood collection (other)
- How long the study runs
- Study runs about 106 months (dates as stated)
- About the drug or intervention
- White blood cell and blood collection — other: Mononucleocytes will be collected via apheresis
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 10
- Started
- 2021-03-24
- Last checked
- 2026-01
Plain English Summary
What is this study?
- • Testing a new treatment for autoimmune diseases
- • Clinical study - 10 participants
- • The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies
Who can take part?
- • Adults
- • Diagnosed with autoimmune diseases
Where?
- • London - Quell Investigator Site 01
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Autoimmune DiseasesInflammationRejection; Transplant, Liver
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting...
See the full criteria
No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.
Where Is This Study? (1 UK site)
Quell Investigator Site 01
London, United Kingdom
How to Get in Touch
Gareth Wright
Sponsor contactCONTACT
+4(0)2070969012 contact@quell-tx.com
Data sourced from ClinicalTrials.gov · Last verified: 2026-01